cd45 cells Search Results


93
Cell Signaling Technology Inc n a cd45 d3f8q rabbit mab cell signaling technology
Figure 6. Longitudinal scRNA-seq analysis of tumor immune compartment reveals anti-tumor CD8+ T cell responses linked to Tyw2 KO (A) In vivo tumor growth following inoculation of WT19, KO13, or KO18 cells into C57BL/6 mice. Time points highlighted with dotted box were used for scRNA-seq analysis. ***p < 0.001, pairwise Bonferroni-corrected Student’s t test. (B) Schematic overview of experimental workflow. Tumors were removed and dissociated at day 18 and day 21 prior to MULTI-seq barcoding, enrichment for <t>CD45+</t> immune cells, and scRNA-seq. (C) Uniform manifold approximation and projection (UMAP) of immune gene expression space colored by cell type. (D) Bar charts of the percentage of CD8+ T cells among all CD45+ cells in each tumor background at day 18 (D18) and day 21 (D21). Statistically significant changes denoted with propeller test p values (ns, not significant; n = 3 sets of 4–5 pooled tumors). (E) UMAP of CD8+ T cell gene expression space colored by subtype. (F) Dot plot of CD8+ T cell subtype annotation genes. Dot color indicates expression level and size indicates the proportion of cells expressing each gene. (G) UMAP of CD8+ T cell gene expression space colored by sample identities on day 18 (top) and day 21 (bottom). Regions of gene expression space that are enriched in Tyw2 KO or WT samples highlighted with dotted circles. (H) Bar charts of the percentage of exhausted and memory-like CD8+ T cells among all CD8+ T cells in each tumor background at day 18 and day 21. Statistically significant changes denoted with propeller test p values (ns, not significant; n = 3 sets of 5 pooled tumors). (I) Z score heatmap of the average expression of immunosuppression markers in CD8+ T cell subtypes. Z scores for each gene clustered using hierarchical clustering. Exhausted CD8+ T cells highlighted with red box. (J) Representative images of the day 21 Tyw2 KO and WT TME with bar charts of mean ± SEM total (top), exhausted (middle), and proliferative CD8+ T cell percentages (bottom). Exact p values from Welch two-sample t test (n = 5 mice per tumor background). (K) Weighted network graph of IFNG-IFNGR1/IFNGR2 predicted signaling interactions split by tumor background and time point. Nodes colored by cell type, edges weighted by signaling probability and colored by sender cell type. See also Figure S6.
N A Cd45 D3f8q Rabbit Mab Cell Signaling Technology, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd45+cells/CD45+Rabbit+mAb/pm40154482-195-189-194
Average 93 stars, based on 1 article reviews
n a cd45 d3f8q rabbit mab cell signaling technology - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc cd45 intracellular domain d9m8i xp rabbit mab
Single cell analysis of patients with collagenous gastritis (A) Workflow for the collection of biopsies from the duodenum and stomach of control and patients with CG. Black and gray arrows indicate which tissues (stomach and duodenum, respectively) were processed by which methods. X indicates the approximate location of all biopsies. (B) Controls (H1-6) and CG biopsies were processed as fresh, unsorted biopsies for gene expression (GEX) libraries; frozen biopsies were <t>CD45-sorted</t> and processed for GEX and T cell receptor (TCR) libraries. CG patient “A” had a pre- and post-steroid biopsy collected for CD45-sorting (“A”; “Apost”), and “D” had a second biopsy (“D2”). (C) UMAP of all patients/samples, both unsorted and CD45-sorted. (D) Violin plot of canonical cluster-defining gene expression across clusters from (C). (E) Cluster frequency per sample. See also and .
Cd45 Intracellular Domain D9m8i Xp Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd45+cells/CD45+(Intracellular+Domain)+XP+Rabbit+mAb/pmc12834102-38-0-9
Average 96 stars, based on 1 article reviews
cd45 intracellular domain d9m8i xp rabbit mab - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc 98819rrid
Single cell analysis of patients with collagenous gastritis (A) Workflow for the collection of biopsies from the duodenum and stomach of control and patients with CG. Black and gray arrows indicate which tissues (stomach and duodenum, respectively) were processed by which methods. X indicates the approximate location of all biopsies. (B) Controls (H1-6) and CG biopsies were processed as fresh, unsorted biopsies for gene expression (GEX) libraries; frozen biopsies were <t>CD45-sorted</t> and processed for GEX and T cell receptor (TCR) libraries. CG patient “A” had a pre- and post-steroid biopsy collected for CD45-sorting (“A”; “Apost”), and “D” had a second biopsy (“D2”). (C) UMAP of all patients/samples, both unsorted and CD45-sorted. (D) Violin plot of canonical cluster-defining gene expression across clusters from (C). (E) Cluster frequency per sample. See also and .
98819rrid, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd45+cells/CD45+Rabbit+mAb/pm40154482-195-197-194
Average 93 stars, based on 1 article reviews
98819rrid - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc monoclonal anti mouse cd45
Figure 8 Gelsolin affects migration of myeloid-derived cells into brain. <t>CD45+</t> cells from gelsolin-treated mice 8 h postburn (A) and quantification of infiltrating CD45+ (B) cells in 10 high power fields (HPF) of the periventricle region following gelsolin treatment. Gelsolin positive cells were seen in medial habenular nucleus (MHb), stria medullaris (sm), hippocampal CA field (CA2) and blood vessel (BV). Magnifications are × 400. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. sham-injured mice; #p < 0.05, ##p < 0.01, ###p < 0.001 vs. placebo mice; + +p < 0.01, and +++p < 0.001 vs. Gsn-L mice by ANOVA, Newman-Keuls post-hoc test. Data are means ± SD for n = 6-8.
Monoclonal Anti Mouse Cd45, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd45+cells/CD45+Mouse+mAb/pm21936896-82-41-51
Average 93 stars, based on 1 article reviews
monoclonal anti mouse cd45 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc rabbit anticd45
Figure 8 Gelsolin affects migration of myeloid-derived cells into brain. <t>CD45+</t> cells from gelsolin-treated mice 8 h postburn (A) and quantification of infiltrating CD45+ (B) cells in 10 high power fields (HPF) of the periventricle region following gelsolin treatment. Gelsolin positive cells were seen in medial habenular nucleus (MHb), stria medullaris (sm), hippocampal CA field (CA2) and blood vessel (BV). Magnifications are × 400. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. sham-injured mice; #p < 0.05, ##p < 0.01, ###p < 0.001 vs. placebo mice; + +p < 0.01, and +++p < 0.001 vs. Gsn-L mice by ANOVA, Newman-Keuls post-hoc test. Data are means ± SD for n = 6-8.
Rabbit Anticd45, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd45+cells/CD45+Rabbit+mAb/pm41381440-64-19-23
Average 96 stars, based on 1 article reviews
rabbit anticd45 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Cell Signaling Technology Inc dqgscgscwafgaveaisdr at5
Peptides identified by LC ESMS from HNE-modified cathepsin B
Dqgscgscwafgaveaisdr At5, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd45+cells/CD45+Rat+mAb/pmc02373537-97-95-135
Average 90 stars, based on 1 article reviews
dqgscgscwafgaveaisdr at5 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
Bio X Cell form bioxcell
Peptides identified by LC ESMS from HNE-modified cathepsin B
Form Bioxcell, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd45+cells/InVivoMAb+anti-mouse+CD45%2E2/pmc12629203-245-3-4
Average 93 stars, based on 1 article reviews
form bioxcell - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc violetfluortm 450 anti mouse cd45
siAtox1/ES@OMV induced cuproptosis and immune cells infiltration in 4T1 tumors in vivo . (A) Representative of immunohistochemical staining of the LIAS and TUNEL staining of tumor tissues from the different treatment groups. Scale bar: 50 μm. (B, C) Quantification of LIAS (B) and TUNEL (C) positive areas. Data are represented as the mean ± SD ( n = 3). (D, E) Serum levels of IL-6 (D) and IFN- α (E) in BALB/c mice at 3 h after systemic administration of PBS, siAtox1@OMV, ES@OMV, or siAtox1/ES@OMV. Data are represented as the mean ± SD ( n = 3). (F–I) Flow cytometry analysis of immune cell ratios in tumor tissue: <t>CD45</t> + cells (F), CD3 + CD45 + T cells (G), CD8 + T cells (gated on CD45 + CD3 + cells) (H), and IFN- γ + in CD8 + T cells (I). Data are represented as the mean ± SD ( n = 3). P values were determined by one-way ANOVA with Tukey’s multiple comparisons test in (B–I). ∗ P < 0.5; ∗∗ P < 0.01; ∗∗∗ P < 0.001.
Violetfluortm 450 Anti Mouse Cd45, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd45+cells/CD45+Rat+mAb/pmc12145039-48-0-15
Average 93 stars, based on 1 article reviews
violetfluortm 450 anti mouse cd45 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc cd45
siAtox1/ES@OMV induced cuproptosis and immune cells infiltration in 4T1 tumors in vivo . (A) Representative of immunohistochemical staining of the LIAS and TUNEL staining of tumor tissues from the different treatment groups. Scale bar: 50 μm. (B, C) Quantification of LIAS (B) and TUNEL (C) positive areas. Data are represented as the mean ± SD ( n = 3). (D, E) Serum levels of IL-6 (D) and IFN- α (E) in BALB/c mice at 3 h after systemic administration of PBS, siAtox1@OMV, ES@OMV, or siAtox1/ES@OMV. Data are represented as the mean ± SD ( n = 3). (F–I) Flow cytometry analysis of immune cell ratios in tumor tissue: <t>CD45</t> + cells (F), CD3 + CD45 + T cells (G), CD8 + T cells (gated on CD45 + CD3 + cells) (H), and IFN- γ + in CD8 + T cells (I). Data are represented as the mean ± SD ( n = 3). P values were determined by one-way ANOVA with Tukey’s multiple comparisons test in (B–I). ∗ P < 0.5; ∗∗ P < 0.01; ∗∗∗ P < 0.001.
Cd45, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd45+cells/CD45+Rat+mAb/pmc07335061__41467_2020_17150_MOESM3_ESM-16-41-42
Average 94 stars, based on 1 article reviews
cd45 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc mllt10
siAtox1/ES@OMV induced cuproptosis and immune cells infiltration in 4T1 tumors in vivo . (A) Representative of immunohistochemical staining of the LIAS and TUNEL staining of tumor tissues from the different treatment groups. Scale bar: 50 μm. (B, C) Quantification of LIAS (B) and TUNEL (C) positive areas. Data are represented as the mean ± SD ( n = 3). (D, E) Serum levels of IL-6 (D) and IFN- α (E) in BALB/c mice at 3 h after systemic administration of PBS, siAtox1@OMV, ES@OMV, or siAtox1/ES@OMV. Data are represented as the mean ± SD ( n = 3). (F–I) Flow cytometry analysis of immune cell ratios in tumor tissue: <t>CD45</t> + cells (F), CD3 + CD45 + T cells (G), CD8 + T cells (gated on CD45 + CD3 + cells) (H), and IFN- γ + in CD8 + T cells (I). Data are represented as the mean ± SD ( n = 3). P values were determined by one-way ANOVA with Tukey’s multiple comparisons test in (B–I). ∗ P < 0.5; ∗∗ P < 0.01; ∗∗∗ P < 0.001.
Mllt10, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd45+cells/CD45+Mouse+mAb/pm37770423-319-217-227
Average 93 stars, based on 1 article reviews
mllt10 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc rat monoclonal
siAtox1/ES@OMV induced cuproptosis and immune cells infiltration in 4T1 tumors in vivo . (A) Representative of immunohistochemical staining of the LIAS and TUNEL staining of tumor tissues from the different treatment groups. Scale bar: 50 μm. (B, C) Quantification of LIAS (B) and TUNEL (C) positive areas. Data are represented as the mean ± SD ( n = 3). (D, E) Serum levels of IL-6 (D) and IFN- α (E) in BALB/c mice at 3 h after systemic administration of PBS, siAtox1@OMV, ES@OMV, or siAtox1/ES@OMV. Data are represented as the mean ± SD ( n = 3). (F–I) Flow cytometry analysis of immune cell ratios in tumor tissue: <t>CD45</t> + cells (F), CD3 + CD45 + T cells (G), CD8 + T cells (gated on CD45 + CD3 + cells) (H), and IFN- γ + in CD8 + T cells (I). Data are represented as the mean ± SD ( n = 3). P values were determined by one-way ANOVA with Tukey’s multiple comparisons test in (B–I). ∗ P < 0.5; ∗∗ P < 0.01; ∗∗∗ P < 0.001.
Rat Monoclonal, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd45+cells/CD45+Rat+mAb/10__1096_slash_fj__202001734r-54-46-65
Average 93 stars, based on 1 article reviews
rat monoclonal - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


Figure 6. Longitudinal scRNA-seq analysis of tumor immune compartment reveals anti-tumor CD8+ T cell responses linked to Tyw2 KO (A) In vivo tumor growth following inoculation of WT19, KO13, or KO18 cells into C57BL/6 mice. Time points highlighted with dotted box were used for scRNA-seq analysis. ***p < 0.001, pairwise Bonferroni-corrected Student’s t test. (B) Schematic overview of experimental workflow. Tumors were removed and dissociated at day 18 and day 21 prior to MULTI-seq barcoding, enrichment for CD45+ immune cells, and scRNA-seq. (C) Uniform manifold approximation and projection (UMAP) of immune gene expression space colored by cell type. (D) Bar charts of the percentage of CD8+ T cells among all CD45+ cells in each tumor background at day 18 (D18) and day 21 (D21). Statistically significant changes denoted with propeller test p values (ns, not significant; n = 3 sets of 4–5 pooled tumors). (E) UMAP of CD8+ T cell gene expression space colored by subtype. (F) Dot plot of CD8+ T cell subtype annotation genes. Dot color indicates expression level and size indicates the proportion of cells expressing each gene. (G) UMAP of CD8+ T cell gene expression space colored by sample identities on day 18 (top) and day 21 (bottom). Regions of gene expression space that are enriched in Tyw2 KO or WT samples highlighted with dotted circles. (H) Bar charts of the percentage of exhausted and memory-like CD8+ T cells among all CD8+ T cells in each tumor background at day 18 and day 21. Statistically significant changes denoted with propeller test p values (ns, not significant; n = 3 sets of 5 pooled tumors). (I) Z score heatmap of the average expression of immunosuppression markers in CD8+ T cell subtypes. Z scores for each gene clustered using hierarchical clustering. Exhausted CD8+ T cells highlighted with red box. (J) Representative images of the day 21 Tyw2 KO and WT TME with bar charts of mean ± SEM total (top), exhausted (middle), and proliferative CD8+ T cell percentages (bottom). Exact p values from Welch two-sample t test (n = 5 mice per tumor background). (K) Weighted network graph of IFNG-IFNGR1/IFNGR2 predicted signaling interactions split by tumor background and time point. Nodes colored by cell type, edges weighted by signaling probability and colored by sender cell type. See also Figure S6.

Journal: Cancer cell

Article Title: Translation dysregulation in cancer as a source for targetable antigens.

doi: 10.1016/j.ccell.2025.03.003

Figure Lengend Snippet: Figure 6. Longitudinal scRNA-seq analysis of tumor immune compartment reveals anti-tumor CD8+ T cell responses linked to Tyw2 KO (A) In vivo tumor growth following inoculation of WT19, KO13, or KO18 cells into C57BL/6 mice. Time points highlighted with dotted box were used for scRNA-seq analysis. ***p < 0.001, pairwise Bonferroni-corrected Student’s t test. (B) Schematic overview of experimental workflow. Tumors were removed and dissociated at day 18 and day 21 prior to MULTI-seq barcoding, enrichment for CD45+ immune cells, and scRNA-seq. (C) Uniform manifold approximation and projection (UMAP) of immune gene expression space colored by cell type. (D) Bar charts of the percentage of CD8+ T cells among all CD45+ cells in each tumor background at day 18 (D18) and day 21 (D21). Statistically significant changes denoted with propeller test p values (ns, not significant; n = 3 sets of 4–5 pooled tumors). (E) UMAP of CD8+ T cell gene expression space colored by subtype. (F) Dot plot of CD8+ T cell subtype annotation genes. Dot color indicates expression level and size indicates the proportion of cells expressing each gene. (G) UMAP of CD8+ T cell gene expression space colored by sample identities on day 18 (top) and day 21 (bottom). Regions of gene expression space that are enriched in Tyw2 KO or WT samples highlighted with dotted circles. (H) Bar charts of the percentage of exhausted and memory-like CD8+ T cells among all CD8+ T cells in each tumor background at day 18 and day 21. Statistically significant changes denoted with propeller test p values (ns, not significant; n = 3 sets of 5 pooled tumors). (I) Z score heatmap of the average expression of immunosuppression markers in CD8+ T cell subtypes. Z scores for each gene clustered using hierarchical clustering. Exhausted CD8+ T cells highlighted with red box. (J) Representative images of the day 21 Tyw2 KO and WT TME with bar charts of mean ± SEM total (top), exhausted (middle), and proliferative CD8+ T cell percentages (bottom). Exact p values from Welch two-sample t test (n = 5 mice per tumor background). (K) Weighted network graph of IFNG-IFNGR1/IFNGR2 predicted signaling interactions split by tumor background and time point. Nodes colored by cell type, edges weighted by signaling probability and colored by sender cell type. See also Figure S6.

Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies anti-TYW2 (TRMT12) Novus-Biologicals Cat#NBP1-76583; RRID: AB_11025190 anti-a tubulin mouse Millipore Cat#05-829; RRID: AB_310035 anti-mCherry Abcam Cat#Ab167453; RRID: AB_2571870 anti-rabbit HRP conjugate Cell Signaling Technology Cat#5127; RRID: AB_10892860 anti-mouse HRP conjugate Cell Signaling Technology Cat#91196; RRID: AB_2940774 pan-HLA antibody W6/32 ATCC ATCC-HB-95RRID; N/A APC anti human HLA A,B,C BioLegend Cat# 311410; RRID: AB_314879 PE anti-human CD3 BioLegend Cat#300308; RRID: AB_314044 FITC anti-human CD8 BioLegend Cat#301060; RRID: AB_2564165 APC anti-human CD137 (41BB) BioLegend Cat#309810; RRID: AB_830672 APC anti- human IFNg BioLegend Cat#502512; RRID: AB_315237 APC anti-human TNFa BioLegend Cat#502912; RRID: AB_315264 APC anti-human CD8 BioLegend Cat#300912; RRID: AB_314116 PE-Cy7 anti-human CD3 BioLegend Cat# 300316; RRID: AB_314052 PE anti- human IFNg BioLegend Cat#502509; RRID: AB_315234 BV421 anti-human TNFa BioLegend Cat# 502932; RRID: AB_10960738 InVivoMAb anti-mouse CD8a, clone 2.43 BioXcell Cat#BE0061; RRID: AB_1125541 InVivoMAb rat IgG2b isotype control, clone LTF-2 BioXcell Cat#BE0090; RRID: AB_1107780 InVivoMAb anti-mouse PD-1 (CD279), clone RMP1-14 BioXcell Cat#BE0146; RRID: AB_10949053 InVivoMAb rat IgG2a isotype control, clone 2A3 BioXcell Cat#BE0089; RRID: AB_1107769 CD8a (D4W2Z) XP Rabbit mAb Cell Signaling Technology Cat#60168RRID; N/A Anti-CD3 epsilon antibody [CAL57] abcam Ab251607RRID; N/A Anti-LAG-3 antibody [CAL77] abcam Ab251606RRID; N/A CD45 (D3F8Q) Rabbit mAb Cell Signaling Technology Cat#98819RRID; N/A BD Pharmingen Purified Mouse Anti-Ki-67 BD Biosciences Cat#556003; RRID: AB_396287 FITC anti-mouse CD3 BioLegend Cat#100203; RRID: AB_312660 (Continued on next page) Cancer Cell 43, 1–18.e1–e18, May 12, 2025 e1

Techniques: In Vivo, Gene Expression, Expressing

Single cell analysis of patients with collagenous gastritis (A) Workflow for the collection of biopsies from the duodenum and stomach of control and patients with CG. Black and gray arrows indicate which tissues (stomach and duodenum, respectively) were processed by which methods. X indicates the approximate location of all biopsies. (B) Controls (H1-6) and CG biopsies were processed as fresh, unsorted biopsies for gene expression (GEX) libraries; frozen biopsies were CD45-sorted and processed for GEX and T cell receptor (TCR) libraries. CG patient “A” had a pre- and post-steroid biopsy collected for CD45-sorting (“A”; “Apost”), and “D” had a second biopsy (“D2”). (C) UMAP of all patients/samples, both unsorted and CD45-sorted. (D) Violin plot of canonical cluster-defining gene expression across clusters from (C). (E) Cluster frequency per sample. See also and .

Journal: iScience

Article Title: Cellular and molecular profiling of collagenous gastritis implicates pathogenic CD4 + T cells

doi: 10.1016/j.isci.2025.114344

Figure Lengend Snippet: Single cell analysis of patients with collagenous gastritis (A) Workflow for the collection of biopsies from the duodenum and stomach of control and patients with CG. Black and gray arrows indicate which tissues (stomach and duodenum, respectively) were processed by which methods. X indicates the approximate location of all biopsies. (B) Controls (H1-6) and CG biopsies were processed as fresh, unsorted biopsies for gene expression (GEX) libraries; frozen biopsies were CD45-sorted and processed for GEX and T cell receptor (TCR) libraries. CG patient “A” had a pre- and post-steroid biopsy collected for CD45-sorting (“A”; “Apost”), and “D” had a second biopsy (“D2”). (C) UMAP of all patients/samples, both unsorted and CD45-sorted. (D) Violin plot of canonical cluster-defining gene expression across clusters from (C). (E) Cluster frequency per sample. See also and .

Article Snippet: CD45 (Intracellular Domain) (D9M8I) XP® Rabbit mAb #13917 , Cell Signaling Technology , 13917S; RRID: AB_2750898.

Techniques: Single-cell Analysis, Control, Gene Expression

Patients with Collagenous gastritis have an influx of highly activated T cells (A) CD4 + and CD8 + T cells were quantified by flow cytometry of the duodenum (top row) or stomach (bottom row). (B) Representative flow plots from (A). (C) CD4:CD8 ratio from (A). (D and E) PD-1 expression on duodenal CD8 + (D) or CD4 + T cells (E). (F and G) PD-1 expression on gastric CD8 + (F) or CD4 + T cells (G). (H) Representative CD8 and CD4 stains from tissue sections. All images at 20x objective. Scale bars 500 μm. (I) Quantification of (H) for intraepithelial (top row) or intraepithelial and stromal lymphocytes (bottom) from slides. Total cells per five high power fields (HPFs). (J) Quantification of PD-L1 and PD-1 stained tissue sections. (K) CD4: CD8 ratio from T cells captured by scRNA-seq (see D) in CD45-sorted samples. Significance assessed by the Wilcoxon rank test. (L) Heatmap of differential gene expression comparing control patients to each CG patient sample for CD8 and CD4 scRNA-seq clusters from CD45+ sorted cells. Genes involved in T cell activation/exhaustion are shown. Dot indicates significantly different expression between a patient sample and all control controls. Data are mean ± SEM; flow percentages were compared with a Student’s t test (flow) or Wilcoxon test (histology) followed by a Benjamini-Hochberg correction. Gene expression data compared with a Benjamini-Hochberg-corrected Wilcoxon rank-sum test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 See also and .

Journal: iScience

Article Title: Cellular and molecular profiling of collagenous gastritis implicates pathogenic CD4 + T cells

doi: 10.1016/j.isci.2025.114344

Figure Lengend Snippet: Patients with Collagenous gastritis have an influx of highly activated T cells (A) CD4 + and CD8 + T cells were quantified by flow cytometry of the duodenum (top row) or stomach (bottom row). (B) Representative flow plots from (A). (C) CD4:CD8 ratio from (A). (D and E) PD-1 expression on duodenal CD8 + (D) or CD4 + T cells (E). (F and G) PD-1 expression on gastric CD8 + (F) or CD4 + T cells (G). (H) Representative CD8 and CD4 stains from tissue sections. All images at 20x objective. Scale bars 500 μm. (I) Quantification of (H) for intraepithelial (top row) or intraepithelial and stromal lymphocytes (bottom) from slides. Total cells per five high power fields (HPFs). (J) Quantification of PD-L1 and PD-1 stained tissue sections. (K) CD4: CD8 ratio from T cells captured by scRNA-seq (see D) in CD45-sorted samples. Significance assessed by the Wilcoxon rank test. (L) Heatmap of differential gene expression comparing control patients to each CG patient sample for CD8 and CD4 scRNA-seq clusters from CD45+ sorted cells. Genes involved in T cell activation/exhaustion are shown. Dot indicates significantly different expression between a patient sample and all control controls. Data are mean ± SEM; flow percentages were compared with a Student’s t test (flow) or Wilcoxon test (histology) followed by a Benjamini-Hochberg correction. Gene expression data compared with a Benjamini-Hochberg-corrected Wilcoxon rank-sum test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 See also and .

Article Snippet: CD45 (Intracellular Domain) (D9M8I) XP® Rabbit mAb #13917 , Cell Signaling Technology , 13917S; RRID: AB_2750898.

Techniques: Flow Cytometry, Expressing, Staining, Gene Expression, Control, Activation Assay

Resident memory CD8 T cells and expanded T cell clonotypes are reduced in patients with CG (A) T cells were sub-clustered from all patients/samples. T RM = Tissue resident memory; T EM = Effector memory; CTL = cytotoxic T lymphocyte. (B) Dot plot of cluster-defining genes for T cell sub-clusters. (C) Sub-cluster frequency per sample. (D) Distribution of T cells split by patient disease status. (E) Barplot of sub-clusters grouped by disease status of the patient. Mean ± SEM; adjusted p -value from BH-adjusted Wilcoxon rank test shown for p-adj <0.1. (F) UMAP from (A) of TCR expansion across all CD45-sorted samples; cells are colored by the TCR frequency. (G) Barplot of unique TCR clonotypes; expanded clonotypes are those with 2+ cells per unique TCR. Percentages above bars indicate the percentage of expanded clonotypes out of the total number of unique clonotypes. (H) Percentage of expanded T cells (2+ cells/clonotype) out of all T cells with TCRs sequenced. (I) Percentage of unique, expanded clonotypes out of all unique clonotypes; similar to (G), but grouped by disease status. Error bars are ±SEM; percentages were compared with a Wilcoxon rank test. See also .

Journal: iScience

Article Title: Cellular and molecular profiling of collagenous gastritis implicates pathogenic CD4 + T cells

doi: 10.1016/j.isci.2025.114344

Figure Lengend Snippet: Resident memory CD8 T cells and expanded T cell clonotypes are reduced in patients with CG (A) T cells were sub-clustered from all patients/samples. T RM = Tissue resident memory; T EM = Effector memory; CTL = cytotoxic T lymphocyte. (B) Dot plot of cluster-defining genes for T cell sub-clusters. (C) Sub-cluster frequency per sample. (D) Distribution of T cells split by patient disease status. (E) Barplot of sub-clusters grouped by disease status of the patient. Mean ± SEM; adjusted p -value from BH-adjusted Wilcoxon rank test shown for p-adj <0.1. (F) UMAP from (A) of TCR expansion across all CD45-sorted samples; cells are colored by the TCR frequency. (G) Barplot of unique TCR clonotypes; expanded clonotypes are those with 2+ cells per unique TCR. Percentages above bars indicate the percentage of expanded clonotypes out of the total number of unique clonotypes. (H) Percentage of expanded T cells (2+ cells/clonotype) out of all T cells with TCRs sequenced. (I) Percentage of unique, expanded clonotypes out of all unique clonotypes; similar to (G), but grouped by disease status. Error bars are ±SEM; percentages were compared with a Wilcoxon rank test. See also .

Article Snippet: CD45 (Intracellular Domain) (D9M8I) XP® Rabbit mAb #13917 , Cell Signaling Technology , 13917S; RRID: AB_2750898.

Techniques:

Memory, Th17, and naive CD4 T cells are reduced, while cytotoxic CD4, Th1, Th2, and Treg populations are increased in patients with CG (A) CD4 T cells were sub-clustered from all patients/samples. (B) Dot plot of cluster-defining genes for CD4 T cell sub-clusters. (C) CD4 sub-cluster frequency per sample. (D) Distribution of T cells, colored by patient disease status. (E) Barplot of CD4 sub-clusters grouped by disease status of patient. Mean ± SEM; adjusted p -value from BH-adjusted Wilcoxon test shown for p-adj <0.1. (F) UMAP from (A) of CD4 clonal expansion across all CD45-sorted samples; cells are colored by the TCR clone frequency. (G) Barplot of unique CD4 TCR clonotypes; expanded clonotypes are those with 2+ cells per unique TCR. Percentages above bars indicate the percentage of expanded clonotypes out of the total number of unique clonotypes. “Patient H5” had fewer than 20 TCRs sequenced and was omitted from the plot. (H) Percentage of expanded T cells (2+ cells/clonotype) out of all T cells with TCRs sequenced (left); percentage of unique, expanded clonotypes out of all unique clonotypes, similar to (G), but grouped by disease status. Error bars are ±SEM; percentages were compared with a Wilcoxon rank test. N.S. not significant. See also .

Journal: iScience

Article Title: Cellular and molecular profiling of collagenous gastritis implicates pathogenic CD4 + T cells

doi: 10.1016/j.isci.2025.114344

Figure Lengend Snippet: Memory, Th17, and naive CD4 T cells are reduced, while cytotoxic CD4, Th1, Th2, and Treg populations are increased in patients with CG (A) CD4 T cells were sub-clustered from all patients/samples. (B) Dot plot of cluster-defining genes for CD4 T cell sub-clusters. (C) CD4 sub-cluster frequency per sample. (D) Distribution of T cells, colored by patient disease status. (E) Barplot of CD4 sub-clusters grouped by disease status of patient. Mean ± SEM; adjusted p -value from BH-adjusted Wilcoxon test shown for p-adj <0.1. (F) UMAP from (A) of CD4 clonal expansion across all CD45-sorted samples; cells are colored by the TCR clone frequency. (G) Barplot of unique CD4 TCR clonotypes; expanded clonotypes are those with 2+ cells per unique TCR. Percentages above bars indicate the percentage of expanded clonotypes out of the total number of unique clonotypes. “Patient H5” had fewer than 20 TCRs sequenced and was omitted from the plot. (H) Percentage of expanded T cells (2+ cells/clonotype) out of all T cells with TCRs sequenced (left); percentage of unique, expanded clonotypes out of all unique clonotypes, similar to (G), but grouped by disease status. Error bars are ±SEM; percentages were compared with a Wilcoxon rank test. N.S. not significant. See also .

Article Snippet: CD45 (Intracellular Domain) (D9M8I) XP® Rabbit mAb #13917 , Cell Signaling Technology , 13917S; RRID: AB_2750898.

Techniques:

Effects of steroid treatment on pre-existing TCR clonotypes and possible future therapies for CG (A) Hallmark Gene Set Enrichment Analysis of all cells from CD45-sorted patient “A”, comparing pre- and post-steroid gene expressions. (B) TCR clones sequenced from patient “A” show the distribution of clonotypes that were shared between time points (pre- and post-steroids) and expanded (2+ cells); expanded but not shared; shared but not expanded; or neither shared nor expanded (not). Percentage of total clone pool for each timepoint shown. (C) Alluvial plot from patient “A” showing unique TCR clones that were expanded (2+ cells) and shared between the two time points (pre- and post-steroids). Flow between bars indicates which sub-cluster the TCR clones were shared between. (D) The top four expanded TCR clones shared between pre- and post-steroids for patient “A” and their T cell sub-clusters of origin. Y axis indicates the total number of T cells captured in each shared clonotype. TCR chains are listed below every four clones. (E) Heatmap of scaled gene expression for T cell activation genes across T cell sub-clusters. Dot indicates significantly different expression between the CG and control samples for a particular gene/cluster. (F) Same as (E), but across CD4 sub-clusters. (G) Expression of IL5 and IL13 in the Th2 subcluster. (H) Differential gene expression analysis was performed across each T cell sub-cluster. Normalized JAK3 expression shown for T cell subclusters in which p-adj ≤0.05. Adjusted p -value and log2 fold-change (LFC) displayed. (I) Same as (H) but for CD4 sub-clusters in which p-adj ≤0.05. (J) Normalized ITGA4 expression shown for T cell subclusters in which p-adj ≤0.05. Adjusted p -value and log2 fold-change (LFC) displayed. (K) Same as (J), but for CD4 sub-clusters in which p-adj ≤0.05. (L) Normalized MADCAM1 (ligand for α4 integrin) on endothelial cells. Gene expression significance assessed by the Wilcoxon rank-sum test with a Benjamini-Hochberg correction. See also .

Journal: iScience

Article Title: Cellular and molecular profiling of collagenous gastritis implicates pathogenic CD4 + T cells

doi: 10.1016/j.isci.2025.114344

Figure Lengend Snippet: Effects of steroid treatment on pre-existing TCR clonotypes and possible future therapies for CG (A) Hallmark Gene Set Enrichment Analysis of all cells from CD45-sorted patient “A”, comparing pre- and post-steroid gene expressions. (B) TCR clones sequenced from patient “A” show the distribution of clonotypes that were shared between time points (pre- and post-steroids) and expanded (2+ cells); expanded but not shared; shared but not expanded; or neither shared nor expanded (not). Percentage of total clone pool for each timepoint shown. (C) Alluvial plot from patient “A” showing unique TCR clones that were expanded (2+ cells) and shared between the two time points (pre- and post-steroids). Flow between bars indicates which sub-cluster the TCR clones were shared between. (D) The top four expanded TCR clones shared between pre- and post-steroids for patient “A” and their T cell sub-clusters of origin. Y axis indicates the total number of T cells captured in each shared clonotype. TCR chains are listed below every four clones. (E) Heatmap of scaled gene expression for T cell activation genes across T cell sub-clusters. Dot indicates significantly different expression between the CG and control samples for a particular gene/cluster. (F) Same as (E), but across CD4 sub-clusters. (G) Expression of IL5 and IL13 in the Th2 subcluster. (H) Differential gene expression analysis was performed across each T cell sub-cluster. Normalized JAK3 expression shown for T cell subclusters in which p-adj ≤0.05. Adjusted p -value and log2 fold-change (LFC) displayed. (I) Same as (H) but for CD4 sub-clusters in which p-adj ≤0.05. (J) Normalized ITGA4 expression shown for T cell subclusters in which p-adj ≤0.05. Adjusted p -value and log2 fold-change (LFC) displayed. (K) Same as (J), but for CD4 sub-clusters in which p-adj ≤0.05. (L) Normalized MADCAM1 (ligand for α4 integrin) on endothelial cells. Gene expression significance assessed by the Wilcoxon rank-sum test with a Benjamini-Hochberg correction. See also .

Article Snippet: CD45 (Intracellular Domain) (D9M8I) XP® Rabbit mAb #13917 , Cell Signaling Technology , 13917S; RRID: AB_2750898.

Techniques: Clone Assay, Gene Expression, Activation Assay, Expressing, Control

Figure 8 Gelsolin affects migration of myeloid-derived cells into brain. CD45+ cells from gelsolin-treated mice 8 h postburn (A) and quantification of infiltrating CD45+ (B) cells in 10 high power fields (HPF) of the periventricle region following gelsolin treatment. Gelsolin positive cells were seen in medial habenular nucleus (MHb), stria medullaris (sm), hippocampal CA field (CA2) and blood vessel (BV). Magnifications are × 400. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. sham-injured mice; #p < 0.05, ##p < 0.01, ###p < 0.001 vs. placebo mice; + +p < 0.01, and +++p < 0.001 vs. Gsn-L mice by ANOVA, Newman-Keuls post-hoc test. Data are means ± SD for n = 6-8.

Journal: Journal of neuroinflammation

Article Title: Treatment with gelsolin reduces brain inflammation and apoptotic signaling in mice following thermal injury.

doi: 10.1186/1742-2094-8-118

Figure Lengend Snippet: Figure 8 Gelsolin affects migration of myeloid-derived cells into brain. CD45+ cells from gelsolin-treated mice 8 h postburn (A) and quantification of infiltrating CD45+ (B) cells in 10 high power fields (HPF) of the periventricle region following gelsolin treatment. Gelsolin positive cells were seen in medial habenular nucleus (MHb), stria medullaris (sm), hippocampal CA field (CA2) and blood vessel (BV). Magnifications are × 400. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. sham-injured mice; #p < 0.05, ##p < 0.01, ###p < 0.001 vs. placebo mice; + +p < 0.01, and +++p < 0.001 vs. Gsn-L mice by ANOVA, Newman-Keuls post-hoc test. Data are means ± SD for n = 6-8.

Article Snippet: Sections used for immunocytochemistry were incubated in 0.3% hydrogen peroxide (H2O2) for 10 min, and incubated free-floating in antibodies (Abs) of polyclonal anti-mouse ionized calcium-binding adapter molecule 1 (Iba-1, 1:1000; Wako, Osaka, Japan), monoclonal anti-mouse CD11b (Mac-1, 1:1000; EuroBioScience, Lund, Sweden), monoclonal anti-mouse CD45 (1:1000; EuroBioScience), or rabbit anti-cleaved caspase-3 (1:50; Cell Signaling, Danvers, MA, USA) with 3% normal goat serum, 0.05%Triton-X in PBS, for 24-48 h rotating at 4°C.

Techniques: Migration, Derivative Assay

Peptides identified by LC ESMS from HNE-modified cathepsin B

Journal:

Article Title: Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues

doi:

Figure Lengend Snippet: Peptides identified by LC ESMS from HNE-modified cathepsin B

Article Snippet: In addition, no other anti-HNE immunoreactive peptides were detected by antibody dot blot analysis of chromatography fractions in separate RP HPLC of tryptic digests of HNE-modified cathepsin B (not shown). table ft1 table-wrap mode="anchored" t5 Table 1. caption a7 Molecular mass Peptides Sequence position Retention time (min) Calculated Observed Error a (Da) Sequence Cathepsin B, A-chain tryptic peptides AT1 1–8 20.2 933.4 933.8 0.4 LPESFDAR AT2* b 9–18 21.7 1271.6 1271.9 0.3 EQWPNCPTIK AT3 19–21 5.6 416.2 416.4 0.2 EIR AT4** 22–41 28.0 2173.3av 2173.4 0.1 DQGSCGSCWAFGAVEAISDR AT4-HNE modified* 22–41 32.1, 32.7 2274.4av 2274.0 0.4 DQGSCGSCWAFGAVEAISDR AT5* 42–47 17.8 742.3 742.5 0.2 ICIHSN Cathepsin B, B-chain tryptic peptides BT1**** 1–36 30.4 3970.4av 3970.4 0 VNVEVSAEDMLTCCGGECGDGCNGGFPSGAWNFWTK BT2 37–37 .NS 146.1 NS — K BT3*** 38–78 .ND 4447.9av ND G GLVSGGLYNSHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPK BT4* 79–81 5.4 393.2 393.4 0.2 CST BT5 82–92 17.7 1287.5 1287.9 0.4 FWTKKGLVSGG BT6 93–95 .ND 390.2 ND — EDK BT7* 96–109 18.3 1598.7 1598.8 0.1 HFGCSSYSVANNEK BT8 110–117 22.7 995.5 995.6 0.1 EIMAEIYK BT9 118–135 31.5 2006.3av 2006.3 0 NGPVEGAFSVYSDFLLYK BT10 136–153 22.9 1898.1av 1897.8 0.3 SGVYQHVSGEIMGGHAIR BT10-HNE modified 136–153 25.4, 30.3 2056.2 2056.8 0.4 SGVYQHVSGEIMGGHAIR BT11 154–183 33.8 3430.7av 3430.6 0.1 ILGWGVENGTPYWLVGNSWNTDWGDNGFFK BT12 184–186 14.4 400.3 400.4 0.2 ILR BT13** 187–204 .ND 1961.2av ND — GQDHCGIESEIVAGMPCT Open in a separate window Bovine cathepsin B peptides identified by LC ESMS in Fig. 4 are listed by subunit, tryptic peptide, residues, total ion current retention time, calculated and observed masses, and amino acid sequences.

Techniques: Modification

siAtox1/ES@OMV induced cuproptosis and immune cells infiltration in 4T1 tumors in vivo . (A) Representative of immunohistochemical staining of the LIAS and TUNEL staining of tumor tissues from the different treatment groups. Scale bar: 50 μm. (B, C) Quantification of LIAS (B) and TUNEL (C) positive areas. Data are represented as the mean ± SD ( n = 3). (D, E) Serum levels of IL-6 (D) and IFN- α (E) in BALB/c mice at 3 h after systemic administration of PBS, siAtox1@OMV, ES@OMV, or siAtox1/ES@OMV. Data are represented as the mean ± SD ( n = 3). (F–I) Flow cytometry analysis of immune cell ratios in tumor tissue: CD45 + cells (F), CD3 + CD45 + T cells (G), CD8 + T cells (gated on CD45 + CD3 + cells) (H), and IFN- γ + in CD8 + T cells (I). Data are represented as the mean ± SD ( n = 3). P values were determined by one-way ANOVA with Tukey’s multiple comparisons test in (B–I). ∗ P < 0.5; ∗∗ P < 0.01; ∗∗∗ P < 0.001.

Journal: Acta Pharmaceutica Sinica. B

Article Title: Targeting copper homeostasis: Akkermansia -derived OMVs co-deliver Atox1 siRNA and elesclomol for cancer therapy

doi: 10.1016/j.apsb.2025.03.014

Figure Lengend Snippet: siAtox1/ES@OMV induced cuproptosis and immune cells infiltration in 4T1 tumors in vivo . (A) Representative of immunohistochemical staining of the LIAS and TUNEL staining of tumor tissues from the different treatment groups. Scale bar: 50 μm. (B, C) Quantification of LIAS (B) and TUNEL (C) positive areas. Data are represented as the mean ± SD ( n = 3). (D, E) Serum levels of IL-6 (D) and IFN- α (E) in BALB/c mice at 3 h after systemic administration of PBS, siAtox1@OMV, ES@OMV, or siAtox1/ES@OMV. Data are represented as the mean ± SD ( n = 3). (F–I) Flow cytometry analysis of immune cell ratios in tumor tissue: CD45 + cells (F), CD3 + CD45 + T cells (G), CD8 + T cells (gated on CD45 + CD3 + cells) (H), and IFN- γ + in CD8 + T cells (I). Data are represented as the mean ± SD ( n = 3). P values were determined by one-way ANOVA with Tukey’s multiple comparisons test in (B–I). ∗ P < 0.5; ∗∗ P < 0.01; ∗∗∗ P < 0.001.

Article Snippet: VioletFluorTM 450 anti-mouse CD45 (83090S) and anti-mouse MHC Class II-violetFluorTM 450 (86628) were purchased from CST (MA, USA).

Techniques: In Vivo, Immunohistochemical staining, Staining, TUNEL Assay, Flow Cytometry